Emma Zahra

Sydney, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Mirtazapine for Methamphetamine Use Disorder: A Randomized Clinical Trial.

Mirtazapine for Methamphetamine Use Disorder: A Randomized Clinical Trial.

Journal: JAMA psychiatry

Published: April 01, 2026

Factors Associated With Opioid Agonist Treatment Engagement and Harm Reduction Service Use: Findings From the New South Wales Opioid Dependence Survey.

Factors Associated With Opioid Agonist Treatment Engagement and Harm Reduction Service Use: Findings From the New South Wales Opioid Dependence Survey.

Journal: Drug and alcohol review

Published: June 24, 2025

The association between mental disorders and treatment retention among people with opioid use disorder receiving opioid agonist treatment: A systematic review and meta-analysis.

The association between mental disorders and treatment retention among people with opioid use disorder receiving opioid agonist treatment: A systematic review and meta-analysis.

Journal: Drug and alcohol dependence

Published: December 11, 2024

A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial.

A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial.

Journal: Trials

Published: March 01, 2024

Baclofen-related deaths in Australia 2000-2022.

Baclofen-related deaths in Australia 2000-2022.

Journal: Forensic science international

Published: February 07, 2024

96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial.

96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial.

Journal: The International journal on drug policy

Published: September 25, 2023

Characteristics and circumstances of volatile solvent misuse-related death in Australia, 2000-2021.

Characteristics and circumstances of volatile solvent misuse-related death in Australia, 2000-2021.

Journal: Clinical toxicology (Philadelphia, Pa.)

Published: April 06, 2023

Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies.

Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies.

Journal: The lancet. Psychiatry

Published: January 19, 2023

Presentations to the emergency department with self-harm or suicidal behaviours: A role for digital mental health services?

Presentations to the emergency department with self-harm or suicidal behaviours: A role for digital mental health services?

Journal: Journal of psychiatric research

Published: November 29, 2021

Economic analysis of out-of-pocket costs among people in opioid agonist treatment: A cross-sectional survey in three Australian jurisdictions.

Economic analysis of out-of-pocket costs among people in opioid agonist treatment: A cross-sectional survey in three Australian jurisdictions.

Journal: The International journal on drug policy

Published: May 24, 2021

Barbiturate-related hospitalisations, drug treatment episodes, and deaths in Australia, 2000-2018.

Barbiturate-related hospitalisations, drug treatment episodes, and deaths in Australia, 2000-2018.

Journal: The Medical journal of Australia

Published: April 14, 2021

Who would try (or use more) cannabis if it were legal?

Who would try (or use more) cannabis if it were legal?

Journal: Drug and alcohol review

Published: April 06, 2021

Showing 1-12 of 15

Last Updated: 09/26/2026